Urinary Problems in Men — Symptoms, Causes & Treatment | MyMedicPlus

Lower urinary tract symptoms (LUTS) are among the most common reasons for men to seek medical attention, affecting over 50% of men above age 50 and nearly all men over 80. LUTS encompass three symptom categories: voiding (obstructive) symptoms from impaired bladder emptying, storage symptoms from overactive or hypersensitive bladder, and post-micturition symptoms. The most common underlying aetiology is benign prostatic hyperplasia (BPH) — a histological diagnosis of non-cancerous prostate gland enlargement that compresses the urethra; however, LUTS in men are not synonymous with BPH, as the two may occur independently. Other important causes that must be actively excluded include prostate cancer (particularly in men with elevated PSA, hard irregular prostate on digital rectal examination, or family history of prostate cancer — though prostate cancer rarely causes LUTS until locally advanced), overactive bladder (OAB) and neurogenic bladder from neurological conditions (Parkinson's disease — LUTS often precede motor symptoms; multiple sclerosis; stroke; diabetic autonomic neuropathy), urethral stricture, bladder dysfunction (detrusor underactivity in older men — poor flow with high post-void residual despite no prostatic obstruction), bladder stones, and urinary tract infection. The International Prostate Symptom Score (IPSS) is a validated 7-item questionnaire scoring symptom severity (mild below 8, moderate 8-19, severe 20-35) that guides treatment decisions and monitors response to therapy. The impact of LUTS on quality of life — particularly from nocturia (sleep disruption), urgency (social embarrassment), and reduced urine flow — is the primary driver for men seeking treatment.

Benign prostatic hyperplasia (BPH — the most common cause of LUTS in men over 50): age-related hyperplasia of both the glandular and stromal components of the transitional zone of the prostate, compressing the urethra and increasing urethral resistance; BPH affects 50% of men by age 60 and 80% by age 80 — driven by lifelong exposure to testosterone-derived dihydrotestosterone (DHT) and oestrogen. The relationship between prostate size and LUTS severity is inconsistent — a small prostate can cause severe symptoms, and a large prostate can be asymptomatic. Overactive bladder (OAB) and detrusor overactivity: idiopathic (most common), or neurogenic from Parkinson's disease (the subthalamic dopaminergic pathways modulating the micturition reflex are progressively lost — LUTS often precede motor symptoms by years); multiple sclerosis (bilateral corticospinal tract lesions); ischaemic stroke (suprapontine lesion causing detrusor overactivity); and diabetic autonomic neuropathy (detrusor underactivity and impaired bladder sensation). Prostate cancer: rarely causes LUTS in early disease; significant LUTS in prostate cancer usually indicates locally advanced disease involving the bladder neck or urethra — requires PSA, MRI, and biopsy for diagnosis. Urethral stricture: scarring from prior gonococcal urethritis, instrumentation, or trauma causing obstructive LUTS indistinguishable from BPH — diagnosed by retrograde urethrogram or uroflowmetry with a low Qmax and intermittent flow pattern. Bladder stones: calculi irritate the detrusor causing storage LUTS (urgency, frequency, haematuria, and strangury); associated with chronic retention and urinary stasis. Medications causing LUTS: anticholinergics (tricyclic antidepressants, antihistamines, antipsychotics — impair detrusor contractility causing retention and overflow); alpha-sympathomimetics (pseudoephedrine in OTC decongestants — contract the internal urethral sphincter causing urinary retention in BPH); diuretics (furosemide, thiazides — cause urgency and frequency from polyuria).

Voiding (obstructive) LUTS — from impaired bladder emptying: weak or poor urinary stream (the most common and bothersome voiding symptom — often compared by patients to a 'dribble' or reduced to a slow stream taking much longer than previously); urinary hesitancy (prolonged difficulty initiating the stream — particularly in cold weather when alpha-adrenergic tone increases, further constricting the prostate); intermittent or interrupted stream (the stream starts and stops repeatedly during a single voiding episode); straining to void (patients bear down abdominally to generate higher detrusor pressure to overcome urethral resistance); terminal dribbling (the stream trickles rather than stopping cleanly); and prolonged voiding time (simple test — count the number of seconds to void; men with significant obstruction may take 45-90 seconds vs. normal 5-15 seconds). Storage LUTS — from impaired bladder reservoir function: urinary frequency above 8 voids per day (daytime pollakiuria — frequent small-volume voids reflecting reduced functional bladder capacity from incomplete emptying or detrusor overactivity); urgency (a sudden, compelling, difficult-to-defer desire to void that, if not immediately attended to, results in urge incontinence — the cardinal symptom of OAB); nocturia (waking two or more times per night to void — the most quality-of-life-impairing LUTS, disrupting sleep and causing daytime fatigue; affects 72% of men over 70 and is the most commonly reported LUTS in population studies); and urge incontinence (involuntary leakage before reaching the toilet). Post-micturition symptoms: sense of incomplete bladder emptying after voiding (reflecting elevated post-void residual, usually above 100 mL); and post-micturition dribble (involuntary leakage of urine from the bulbar urethra immediately after voiding — very common, embarrassing, and unrelated to bladder neck pathology). IPSS quantifies severity (mild below 8, moderate 8-19, severe 20-35) and guides treatment.

International Prostate Symptom Score (IPSS) questionnaire: 7 validated questions on frequency, nocturia, weak stream, hesitancy, intermittency, incomplete emptying, and urgency — scored 0-35 with an additional QoL question ('If you were to spend the rest of your life with your current urinary symptoms, how would you feel?'); completed before every consultation to objectify severity and monitor treatment response. Digital rectal examination (DRE): assessment of prostate size (normal below 20-25 g — enlarged in BPH; the median lobe is not palpable by DRE and may cause severe obstruction with a normal-feeling prostate), consistency (smooth rubbery elastic — BPH; hard, irregular, nodular — prostate cancer requiring immediate PSA and MRI referral), and symmetry. PSA (prostate-specific antigen): offered to all men with LUTS above age 45 after informed discussion about its limitations (elevated PSA may indicate BPH, prostatitis, or cancer; normal PSA does not exclude cancer) — significantly elevated PSA (above 10 ng/mL) warrants prostate MRI (mpMRI) and biopsy. Urinalysis and midstream urine culture: identifies glycosuria (diabetes mellitus causing polyuria with storage LUTS), haematuria (requires cystoscopy to exclude bladder cancer in any man above 45 with haematuria plus LUTS), and UTI (acute or chronic infection causing storage LUTS). Uroflowmetry: the patient voids into a calibrated electronic flow meter — Qmax (maximum urinary flow rate) below 10 mL/s indicates significant obstruction or poor detrusor contractility; requires voided volume above 150 mL for validity; the flow curve shape provides additional information (plateau curve in stricture; intermittent abdominal straining pattern in detrusor underactivity). Post-void residual (PVR) ultrasound: above 100-150 mL suggests incomplete emptying; above 300 mL indicates significant chronic retention with overflow risk and renal impairment risk. Renal function (eGFR and serum creatinine): long-standing bilateral upper tract obstruction from BPH causes hydronephrosis and progressive CKD — check in all men with significantly elevated PVR, bilateral hydronephrosis on ultrasound, or history of recurrent UTIs. Bladder diary (frequency-volume chart): patient records all voids for 3 days including time, volume, urgency, and incontinence episodes — characterises whether nocturia is from nocturnal polyuria (nocturia index above 1/3) or from OAB. Urodynamics (cystometry plus pressure-flow study): differentiates bladder outlet obstruction from detrusor underactivity in men with LUTS and high PVR when the diagnosis is uncertain before surgery.

Watchful waiting + lifestyle advice for mild LUTS (IPSS <8): reduce evening fluids, limit caffeine/alcohol, double voiding, pelvic floor exercises. Alpha-1 blockers (tamsulosin 0.4 mg, alfuzosin 10 mg): rapid relief (1-2 weeks), relax smooth muscle in prostate and bladder neck. 5-ARI (finasteride 5 mg, dutasteride 0.5 mg): reduce prostate volume over 3-6 months (for prostates >40 mL). Combination alpha-blocker + 5-ARI for large prostates with significant symptoms. OAB: anticholinergics or mirabegron for storage symptoms. Surgery: TURP (gold standard), laser prostatectomy (HoLEP, GreenLight), Urolift (prostatic urethral lift) for moderate disease. Regular monitoring of treatment response, early detection of side effects, and ongoing assessment of disease progression are essential components of optimising patient outcomes over the long term. Treatment plans should be proactively reviewed and appropriately adjusted based on clinical response, patient-reported tolerability, changing patient circumstances, and continuously evolving evidence-based clinical guidelines. Meaningful shared decision-making between patients and their healthcare team, incorporating patient values and treatment preferences, consistently improves both treatment adherence and long-term outcomes.

Acute urinary retention (AUR): sudden inability to void — requires catheterization. Recurrent UTIs (stagnant urine), bladder stones, bladder diverticula, detrusor hypertrophy, chronic urinary retention with overflow incontinence, hydronephrosis, and progressive renal impairment from back-pressure. Post-TURP complications: retrograde ejaculation (80-90%), erectile dysfunction (rare), TUR syndrome (rare), and bladder neck contracture. Long-term specialist follow-up and structured regular review are essential to detect and appropriately manage complications at the earliest possible stage, minimising long-term disability, preserving organ function, and improving the overall prognosis. Patient education about the early warning signs of complications and clear guidance on when to seek urgent medical attention empowers timely help-seeking behaviour and reduces preventable serious adverse outcomes. Psychological impact — including depression, anxiety, and reduced quality of life — should be proactively assessed and addressed as part of comprehensive complication management.

Healthy lifestyle (maintain BMI below 30, regular exercise reduces LUTS severity). Reduce caffeine and alcohol. Evening fluid restriction. Avoid medications worsening LUTS (decongestants, antihistamines, anticholinergics). Prompt treatment of urinary infections. Regular prostate health review from age 50 (or 45 in Black men or those with family history of prostate cancer). Annual IPSS scoring to monitor symptom progression. Sustained lifestyle modifications — maintaining a healthy body weight through balanced diet and regular physical activity, avoiding tobacco smoking, limiting alcohol intake, and managing chronic conditions such as hypertension and diabetes — are foundational strategies for reducing the risk of this condition and its complications. Regular health screening in at-risk populations, rigorous adherence to prescribed preventive medications, and proactive monitoring of established risk factors are equally critical and complementary components of a comprehensive and effective long-term prevention strategy.

See your GP if you experience: difficulty starting to urinate or a weak urine stream; need to urinate more than 8 times per day or frequently at night (nocturia); a sense of incomplete bladder emptying; or any change in urinary pattern that is affecting your sleep or daily activities — particularly if you are aged over 50. Blood in the urine (haematuria) always requires prompt assessment — while often benign (UTI, kidney stones), it must be investigated to exclude bladder or kidney cancer. Seek same-day urgent assessment for: inability to urinate despite feeling the urge (acute urinary retention — extremely painful, requires immediate bladder catheterisation); high fever with loin pain and rigors (pyelonephritis or urosepsis — requires IV antibiotics); and pain at the tip of the penis with dysuria and urethral discharge (urethritis — may be gonorrhoea or chlamydia). All men over 45 with new LUTS should have a PSA blood test offered after informed discussion — to exclude prostate cancer as a contributing cause.